{
  "id": "enwiki-001370865399",
  "slug": "dinaciclib",
  "title": "Dinaciclib",
  "qid": "",
  "lead": "Dinaciclib (SCH-727965) is an experimental drug that inhibits cyclin-dependent kinases (CDKs). It is being evaluated in clinical trials for various cancer indications. Dinaciclib is being developed by Merck & Co. It was granted orphan drug status by the FDA in 2011.",
  "body": "Dinaciclib (SCH-727965) is an experimental drug that inhibits cyclin-dependent kinases (CDKs). It is being evaluated in clinical trials for various cancer indications. Dinaciclib is being developed by Merck & Co. It was granted orphan drug status by the FDA in 2011.",
  "categories": [
    "109487192",
    "23118434",
    "23603337",
    "24409354",
    "26220375",
    "27351776",
    "31369216",
    "43371251",
    "50769796",
    "60213898",
    "63007578",
    "72504547"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1370865399",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1787485364.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001370865399",
    "type": "webpage",
    "title": "Dinaciclib",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/dinaciclib",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001370865399",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1370865399",
    "note": "Immutable snapshot enwiki-001370865399"
  }
}